ABL1 and hematopoietic and lymphoid system neoplasm: Despite the reported pro-cancerogenic effects of extra centrosomes (22), we did not observe any difference in tumor latency in oncogene-driven blood cancer induced by the overexpression of MYC or ABL kinase, when combined with continued Plk4 transgene expression (Fig. 1, A and E).